Artificial Intelligence News and Resources

Podcast

How NVIDIA’s AI Platforms are Reshaping the Future of BioPharma R&D

“We can cut preclinical development from five years to 18 months. Molecules which are AI-enabled in some way seem to be doing better in Phase 1 than standard molecules.” – Dr. Eva-Maria Hempe, Head of Healthcare & Life Sciences EMEA

5 March 2025

CDMO Live Spotlight

How To Implement AI in GMP Manufacturing: Interview with Aizon

Aizon is on a mission to integrate modern computing into the complex arena of GMP manufacturing processes in life sciences. In the latest episode of the PharmaSource podcast we sat down with Claus Abildgren, Chief Revenue Officer at Aizon, and

21 May 2024

Chart

40% of Pharma Companies Are Including Savings from Generative AI in 2024 Budgets

Pharma companies have high confidence in the value of generative artificial intelligence (AI). According to a recent Bain survey:

5 March 2024

Artificial Intelligence News and Resources

How NVIDIA’s AI Platforms are Reshaping the Future of BioPharma R&D

How To Implement AI in GMP Manufacturing: Interview with Aizon

40% of Pharma Companies Are Including Savings from Generative AI in 2024 Budgets

Welcome to PharmaSource

Follow us

Top Links

Get in touch